figshare
Browse
13023_2021_1990_MOESM1_ESM.docx (126.25 kB)

Additional file 1 of Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan

Download (126.25 kB)
journal contribution
posted on 2021-08-10, 03:43 authored by Naoki Iijima, Junji Yamauchi, Naoko Yagishita, Natsumi Araya, Satoko Aratani, Kenichiro Tanabe, Tomoo Sato, Ayako Takata, Yoshihisa Yamano
Additional file 1. Supplementary methods. HAM-net. Table S1. HAM/TSP-bladder dysfunction symptom score (HAM-BDSS). Table S2. Osame Motor Disability Score (OMDS). Table S3. Baseline characteristics of patients with the consecutive 6-year follow-up (Set B). Table S4. Medications for urinary symptoms prescribed in patients with HAMBDSG 0–I (Set C). Table S5. Characteristics of patients for the analysis of the therapeutic effects of mirabegron (Set D). Figure S1. HAM/TSP-bladder dysfunction severity grade (HAM-BDSG).

Funding

Japan Agency for Medical Research and Development Ministry of Health, Labour and Welfare

History

Usage metrics

    Orphanet Journal of Rare Diseases

    Categories

    Keywords

    Human T-cell leukemia virus type 1Human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesisNeurogenic bladderUrinary symptom scoreMirabegron

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC